Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | HPGD | P15428 | 3/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.57 |
| ▸ | BLM | P54132 | 2/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | WRN | Q14191 | 1/20 | 0.57 |
| ▸ | GSK3A | P49840 | 2/20 | 0.46 |
| ▸ | GSK3B | P49841 | 2/20 | 0.46 |
| ▸ | MGLL | Q99685 | 7/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28981237 | 0.98 | ALDH1A1 (0.55) | ALDH1A1HPGDHIF1ABLMCYP1A2 | |
| SCHEMBL714989 | 0.83 | ALDH1A1 (0.44) | ALDH1A1HPGDHIF1ABLMCYP1A2 | |
| SCHEMBL269178 | 0.82 | ALDH1A1 (0.41) | ALDH1A1HPGDHIF1ABLMCYP1A2 | |
| SCHEMBL2581743 | 0.82 | ALDH1A1 (0.41) | ALDH1A1HPGDHIF1ABLMCYP1A2 | |
| SCHEMBL28168374 | 0.80 | ALDH1A1 (0.42) | ALDH1A1HPGDHIF1ABLMCYP1A2 | |
| SCHEMBL209163 | 0.79 | DGKA (0.44) | ALDH1A1HPGDHIF1ABLMCYP1A2 | |
| SCHEMBL557952 | 0.78 | ALDH1A1 (0.38) | ALDH1A1HPGDHIF1ABLMCYP1A2 | |
| SCHEMBL16862478 | 0.78 | ALDH1A1 (0.38) | ALDH1A1HPGDHIF1ABLMCYP1A2 | |
| SCHEMBL9809890 | 0.78 | ALDH1A1 (0.38) | ALDH1A1HPGDHIF1ABLMCYP1A2 | |
| SCHEMBL22203032 | 0.78 | ALDH1A1 (0.38) | ALDH1A1HPGDHIF1ABLMCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 346 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025243208-A2 | PROCESS FOR THE PREPARATION AND/OR PURIFICATION OF POLYETHYLENE GLYCOL AND ITS DERIVATIVES, OBTAINED PRODUCT AND USES THEREOF | HOVIONE - FARMACIÊNCIA, SA (PT) | 2025-11-27 | — | — | WO | claimed |
| US-20250135043-A1 | DUAL-TARGETING COMPOUND FOR FIBROBLAST ACTIVATION PROTEIN (FAP) AND INTEGRIN avB3, PREPARATION METHOD THEREFOR AND USE THEREOF | YANTAI LANNACHENG BIOTECHNOLOGY CO., LTD. (CN) | 2025-05-01 | — | — | US | claimed |
| CN-119736236-A | Hydrogel for 3D culture of stem cells/organoids and preparation method thereof | 昆明理工大学 | 2025-04-01 | — | — | CN | claimed |
| CN-118290405-B | Fluorescent probe for targeting SLC7A5 high-expression tumor and preparation method and application thereof | 江苏省人民医院（南京医科大学第一附属医院） | 2025-02-28 | — | — | CN | claimed |
| CN-119529003-A | Albumin-binding doxorubicin prodrug, self-assembled nanoparticle thereof and application thereof | 沈阳药科大学 | 2025-02-28 | — | — | CN | claimed |
| CN-118290405-A | Fluorescent probe for targeting SLC7A5 high-expression tumor and preparation method and application thereof | 江苏省人民医院（南京医科大学第一附属医院） | 2024-07-05 | — | — | CN | claimed |
| CN-115895176-A | Rubber processing aid and preparation method thereof | 常州市五洲环保科技有限公司 | 2023-04-04 | — | — | CN | claimed |
| CN-111214461-B | Preparation and application of sugar-targeted modified siRNA (small interfering ribonucleic acid) nanoparticles | 河南大学 | 2021-04-16 | — | — | CN | claimed |
| CN-110054984-B | Preparation method of covalent cross-linking self-healing antibacterial coating with stable structure | 常州大学 | 2021-03-05 | — | — | CN | claimed |
| CN-112321684-A | Paclitaxel-antibacterial peptide conjugate, synthesis method and application of paclitaxel-antibacterial peptide conjugate in inhibiting cancer activity | 红河学院 | 2021-02-05 | — | — | CN | claimed |
| EP-3083780-A1 | UNINFLAMMABLE PVDF FILM THAT IS RESISTANT TO TEARING AT LOW TEMPERATURES | Arkema France (FR) | 2016-10-26 | — | — | EP | claimed |
| WO-2015092282-A1 | UNINFLAMMABLE PVDF FILM THAT IS RESISTANT TO TEARING AT LOW TEMPERATURES | ARKEMA FRANCE (FR) | 2015-06-25 | — | — | WO | claimed |
| CN-103732238-A | Therapeutic compounds for immunomodulation | AURIGENE DISCOVERY TECH LTD | 2014-04-16 | — | — | CN | claimed |
| CN-101918841-A | Peptide-lipid constructs and their use in diagnostic and therapeutic applications | CRISTINA-SIMONA WEINBERG | 2010-12-15 | — | — | CN | claimed |
| CN-101696240-A | Long lasting growth hormone releasing factor derivatives | CONJUCHEM INC | 2010-04-21 | — | — | CN | claimed |
| CN-100480239-C | Method for synthesizing N-hydroxy thiosuccinimide salt | ENZI PHARMACEUTICAL NANJING CO (CN) | 2009-04-22 | — | — | CN | claimed |
| CN-1935790-A | Method for synthesizing N-hydroxy thiosuccinimide salt | ENZI PHARMACEUTICAL NANJING CO (CN) | 2007-03-28 | — | — | CN | claimed |
| US-12565506-B2 | Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals | Clarity Pharmaceuticals Ltd (AU) | 2026-03-03 | — | — | US | disclosed |
| CN-1351611-A | Long-acting Fusion Peptide Inhibitors of Viral Infection | CONJUCHEM INC (CA) | 2002-05-29 | — | — | CN | disclosed |
| WO-2001057526-A1 | METHOD FOR ANALYSIS OF REACTION PRODUCTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2001-08-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565506-B2 | Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals | CA12, CLTC, CA13 | ALDH1A1 2510/4885HPGD 2787/4885HIF1A 556/4885 |
| US-20250135043-A1 | DUAL-TARGETING COMPOUND FOR FIBROBLAST ACTIVATION PROTEIN (FAP) AND INTEGRIN avB3, PREPARATION METHOD THEREFOR AND USE THEREOF | FAP, ITGAV, ITGB3 | ALDH1A1 1800/4885HPGD 4225/4885HIF1A 1024/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.